Literature DB >> 32504335

Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.

Kentaro Moriichi1, Hiroki Tanabe2, Yusuke Ono3, Yu Kobayashi1, Yuki Murakami1, Takuya Iwama1, Takehito Kunogi1, Takahiro Sasaki1, Keitaro Takahashi1, Katsuyoshi Ando1, Nobuhiro Ueno1, Shin Kashima1, Hidehiro Takei4, Yusuke Mizukami1,3, Mikihiro Fujiya1, Toshikatsu Okumura1.   

Abstract

INTRODUCTION: Familial adenomatous polyposis (FAP) is typically characterized by more than hundred adenomatous polyps in the colorectum, caused by germline APC mutation. A small proportion of the polyps progress to colorectal adenocarcinoma via adenoma-carcinoma sequence. Serrated lesions and polyps, characterized by a serrated architecture of the epithelium, are noted for two types of genetic pathways in colorectal carcinogenesis. BRAF and KRAS mutations are observed in the serrated pathway. CASE REPORT: We report a young FAP patient with rectal serrated adenomas that were removed by colonoscopic procedures. The histological features with villiform projections and slit-like serration indicated traditional serrated adenoma. A genetic examination with next-generation sequencing showed a somatic BRAF mutation in the serrated adenoma and APC mutations in the tubular adenomas. His germline mutation was found at APC p.Q1928fs*.
CONCLUSION: Serrated adenomas with dual genetic alterations in a FAP patient may be associated with colorectal carcinogenesis and should be considered a target lesion for treatment. The present study demonstrated the malignant potential of serrated adenoma in a FAP patient.

Entities:  

Keywords:  Colorectal cancer; Genetic tumor syndrome; Next-generation sequencing; TSA

Mesh:

Substances:

Year:  2020        PMID: 32504335     DOI: 10.1007/s00384-020-03657-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  11 in total

1.  Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA).

Authors:  Emina Emilia Torlakovic; Jose D Gomez; David K Driman; Jeremy R Parfitt; Chang Wang; Tama Benerjee; Dale C Snover
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

2.  Clinicopathological and molecular correlations in traditional serrated adenoma.

Authors:  Shigeki Sekine; Satoshi Yamashita; Masayoshi Yamada; Taiki Hashimoto; Reiko Ogawa; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Toshikazu Ushijima; Yutaka Saito
Journal:  J Gastroenterol       Date:  2020-02-12       Impact factor: 7.527

3.  Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation.

Authors:  T Matsumoto; M Iida; Y Kobori; M Mizuno; S Nakamura; K Hizawa; T Yao
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

4.  Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma.

Authors:  Takafumi Hiromoto; Takashi Murakami; Yoichi Akazawa; Noriko Sasahara; Tsuyoshi Saito; Naoto Sakamoto; Hiroyuki Mitomi; Akihito Nagahara; Takashi Yao
Journal:  Histopathology       Date:  2018-06-22       Impact factor: 5.087

5.  Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.

Authors:  Michiko Miyaki; Takeru Iijima; Tatsuro Yamaguchi; Tsuyoki Kadofuku; Nobuaki Funata; Takeo Mori
Journal:  Cancer Lett       Date:  2004-07-28       Impact factor: 8.679

6.  Molecular characteristics of serrated adenomas of the colorectum.

Authors:  E J Sawyer; A Cerar; A M Hanby; P Gorman; M Arends; I C Talbot; I P M Tomlinson
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

7.  Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.

Authors:  Eui Jin Lee; Cheol Keun Park; Jong-Won Kim; Dong Kyung Chang; Kyoung-Mee Kim
Journal:  APMIS       Date:  2007-08       Impact factor: 3.205

8.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

9.  Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.

Authors:  Tamotsu Sugai; Makoto Eizuka; Yasuko Fujita; Keisuke Kawasaki; Eiichiro Yamamoto; Kazuyuki Ishida; Hiroo Yamano; Hiromu Suzuki; Takayuki Matsumoto
Journal:  Dig Dis Sci       Date:  2018-07-05       Impact factor: 3.199

10.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.